Last reviewed · How we verify
An Open Label Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing in Human Subjects
This is an open label study. The study will consist of 1 treatment group: coated Nifedipine suppository containing 12 mg of Nifedipine, administered BID to subjects with chronic anal fissure.
Details
| Lead sponsor | RDD Pharma Ltd |
|---|---|
| Phase | Phase 1/Phase 2 |
| Status | COMPLETED |
| Enrolment | 20 |
| Start date | 2009-12 |
| Completion | 2011-02 |
Conditions
- Chronic Anal Fissure
Interventions
- Nifedipine coated suppositories
Primary outcomes
- To examine the effect of coated Nifedipine suppository on Anal fissure pain. — 8 weeks
- To examine the effect of coated Nifedipine suppository on Anal fissure healing. — 8 weeks
Countries
Israel